other material
confidence high
sentiment positive
materiality 0.50
Scribe Therapeutics adopts amended charter and bylaws upon closing of IPO
Scribe Therapeutics, Inc.
- Filed Amended and Restated Certificate of Incorporation and Bylaws effective July 27, 2026.
- Amendments adopted in connection with closing of initial public offering (IPO).
- IPO described in final prospectus dated July 23, 2026 (Registration Statement S-1).
- Board and stockholders previously approved the amendments prior to IPO closing.
- Charter and Bylaws filed as Exhibits 3.1 and 3.2 to this 8-K.